This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
28 Feb 2011

Derma Granted $4.5M for Skin Injury Drug

To pre-clinically investigate the use of DSC127, the US Government has awarded Derma Sciences a $4.5m grant, in the treatment of skin injuries associated with acute radiation exposure.

With the purpose to pre-clinically investigate the use of DSC127, the US Government has awarded Derma Sciences a $4.5m grant, in the treatment of skin injuries associated with acute radiation exposure. DSC127 is a novel angiotensin analogue, which has been shown to improve epithelialisation, granulation, vascularisation, and accelerate wound healing in a variety of normal and diabetic animal models.

 

The 16-month grant was awarded by the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority.

 

The contract is a part of the deaprtment's radiological and nuclear threats preparedness strategy, and could be extended for a total of five

Related News